Comparison between Fondaparinux and Low-Molecular-Weight Heparin in Patients with Acute Coronary Syndrome: A Meta-Analysis.

MLA

Qiao, Jianzhong, et al. “Comparison between Fondaparinux and Low-Molecular-Weight Heparin in Patients with Acute Coronary Syndrome: A Meta-Analysis.” Cardiology, vol. 133, no. 3, Feb. 2016, pp. 163–72. EBSCOhost, https://doi.org/10.1159/000441442.

APA

Qiao, J., Zhang, X., Zhang, J., Li, P., Xu, B., Wang, S., Jiang, H., Shen, Y., & Wang, K. (2016). Comparison between Fondaparinux and Low-Molecular-Weight Heparin in Patients with Acute Coronary Syndrome: A Meta-Analysis. Cardiology, 133(3), 163–172. https://doi.org/10.1159/000441442

Chicago

Qiao, Jianzhong, Xinlin Zhang, Jingmei Zhang, Peiwen Li, Biao Xu, Shang Wang, He Jiang, Yu Shen, and Kun Wang. 2016. “Comparison between Fondaparinux and Low-Molecular-Weight Heparin in Patients with Acute Coronary Syndrome: A Meta-Analysis.” Cardiology 133 (3): 163–72. doi:10.1159/000441442.